Find an expert

A/Prof Mark D. Chatfield is a highly experienced statistician and clinical trialist working at the UQ Clinical Trials Centre.

In collaboration with health and medical researchers, he has published >200 times in academic journals. He has been an investigator on 27 NHMRC/MRFF funded (>$50M) studies (mostly clinical trials). He has co-supervised 5 PhD students to completion, and is currently an advisor to 4 PhD students. He has over 20 years of experience as a biostatistician in Australia (Brisbane | Darwin | Sydney) and the UK (Cambridge, 2002-2009).

He plays an active role in the Australian Clinical Trials Alliance Statistics in Trials Interest Group.

Stata users around the world enjoy using his table1_mc command.

He is an Honorary Fellow (Associate Professor) with Menzies School of Health Research.

Dr Stephane Dufau is an Honorary Senior Research Fellow in Cognitive neuroscience within the Queensland Brain Institute, The University of Queensland. Stephane is a Senior Research Fellow at Mater Research (Mater Epilepsy Unit Research group). He worked as a Research Engineer at CNRS, France (currently on unpaid leave).

I studied Technical Mathematics at the Vienna University of Technology. I also earned a Master's degree in Law and I finished the first ("non-clinical") part of Medical Studies at the University of Vienna. I earned my PhD in Applied Mathematics at the University of Vienna in 2007. My PhD advisor was Christian Schmeiser, my co-advisor was Peter Markowich. I spent several months at the University of Buenos Aires working with C. Lederman and at the ENS-Paris rue d'Ulm in the group of B. Perthame.

Before coming to UQ, I held post-doc positions at the Wolfgang Pauli Insitute (Vienna), University of Vienna and the Austrian Academy of Sciences (RICAM). In 2013 I won an Erwin Schrödinger Fellowship of the Austrian Science Fund (FWF). I was a post-doc researcher in the group of Alex Mogilner first at UC Davis, then at the Courant Institute of Math. Sciences (New York University).

A/Prof Benn Sartorius is an established spatial and global health epidemiologist, with a particular interest in the burden of infectious disease and attributable determinants at sub-national, national and global scales as a tool to help inform and optimise policy at national and subnational scales. Dr Sartorius a principal research fellow in UQ's ODeSI team at University of Queensland, an affiliate professor in Department of Health Metric Sciences at University of Washington and a honorary visiting research fellow at University of Oxfored. Prior to join UQ, Dr Sartorius was the principal investigator for the Global Research on Antimicrobial Resistance (GRAM) Project based in the Centre for Tropical Medicine and Global Health at University of Oxford.

Dr Sartorius' research has focused on better understanding the spatial-temporal burden and risk factors of multiple IDs, including mosquito-borne diseases such as malaria, sexually transmitted infections, neglected tropical diseases such as soil-transmitted helminths and onchocerciasis, vaccine preventable diseases, emerging infectious diseases and more recently focused on antimicrobial resistance. These and other examples highlight the utility of spatial epidemiology to identify higher risk areas that should be prioritised for more targeted, tailored and resource efficient intervention and control measures. However, often spatial risk estimates for IDs are often not produced in-country in settings such as the Pacific, where disease burden is high and local modelling expertise is limited, resulting in use of incomplete/biased data and resulting in inefficient and suboptimal decision-making. I’ve been a collaborator on the Global Burden of Disease (GBD) project since 2014 and the Scientific Council for the GBD Project since 2015. Dr Sartorius is a member of the WHO Reference Group on Health Statistics (RGHS) and chair of the Age-Specific Mortality Estimation and Life Table Computation task force. Benn's vision, through ODeSI-HERA, is to expand his international profile and leadership in spatial-temporal epidemiology of priority infectious diseases in Australia and the Pacific. This will include spatial epidemiological innovation, and capacity building to improve health outcomes in high-risk and vulnerable sub-populations within the region, and will be co-created with stakeholders in the region to ensure that it aligns with their priorities, and support precision-based decision-making systems to help policy makers optimise resource allocation and guide targeted interventions.